OTC: SFOSF - Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
半年間の収益性: +4.94%
配当利回り: +2.26%
セクタ: Healthcare
半年間の収益性: +4.94%
配当利回り: +2.26%
セクタ: Healthcare